Safety of targeted therapies for treating immune-mediated inflammatory diseases

被引：0

作者：

Hoisnard, L. ^{[1
]}

Zureik, M. ^{[2
]}

Weill, A. ^{[2
]}

Dray-Spira, R. ^{[2
]}

Lebrun-Vignes, B. ^{[3
]}

Meyer, A. ^{[4
]}

Vegas, L. Pina ^{[5
]}

Claudepierre, P. ^{[5
]}

Mahevas, M. ^{[6
]}

Michel, M. ^{[6
]}

Cohen, J. L. ^{[7
]}

Maury, S. ^{[8
]}

El Karoui, K. ^{[9
]}

Wolkenstein, P. ^{[10
]}

Roy, L. ^{[11
]}

Amiot, A. ^{[12
]}

Grimbert, P. ^{[9
]}

Sbidian, E. ^{[10
]}

机构：

[1] Federat Hospitalo Univ True Innovat Therapy Immun, Hop Henri Mondor, Creteil, France

[2] French Natl Hlth Insurance, French Natl Agcy Med & Hlth Prod Safety, EpiPhare Sci Interest Grp Epidemiol Hlth Prod, St Denis, France

[3] Hop La Pitie Salpetriere, Serv Pharmacol, Paris, France

[4] Hop Bicetre, Serv Gastroenterol, Le Kremlin Bicetre, France

[5] Hop Henri Mondor, Serv Rhumatol, Creteil, France

[6] Hop Henri Mondor, Serv Med Interne, Creteil, France

[7] INSERM, Inst Mondor Rech Biomed, Creteil, France

[8] Hop Henri Mondor, Serv Dhematol, Creteil, France

[9] Hop Henri Mondor, Serv Nephrol & Transplantat, Creteil, France

[10] Hop Henri Mondor, Serv Dermatol, Creteil, France

[11] Hop Henri Mondor, Serv Dhematol Clin, Creteil, France

[12] Hop Henri Mondor, Serv GastroEnterol, Creteil, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2024年 / 38卷

关键词：

French National Health Data System; immune-mediated inflammatory diseases; Janus kinase inhibitors; pharmacoepidemiology; pharmacovigilance; safety;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

TH-002

引用

页码：43 / 44

页数：2

共 50 条

[21] The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Forbes, Jessica D.
Van Domselaar, Gary
Bernstein, Charles N.
FRONTIERS IN MICROBIOLOGY, 2016, 7
[22] Biologics in Inflammatory Immune-mediated Systemic Diseases
Moroncini, Gianluca
Calogera, Giovanni
Benfaremo, Devis
Gabrielli, Armando
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (12) : 1008 - 1016
[23] Travelers With Immune-Mediated Inflammatory Diseases: Are They Different?
Jaeger, Veronika K.
Rueegg, Rolanda
Steffen, Robert
Hatz, Christoph
Buehler, Silja
JOURNAL OF TRAVEL MEDICINE, 2015, 22 (03) : 161 - 167
[24] A role for leptin in immune-mediated inflammatory diseases?
C Gabay
G Palmer
Arthritis Res Ther, 6 (Suppl 3):
[25] The role of platelets in immune-mediated inflammatory diseases
Marc Scherlinger
Christophe Richez
George C. Tsokos
Eric Boilard
Patrick Blanco
Nature Reviews Immunology, 2023, 23 : 495 - 510
[26] Vaccinations in patients with immune-mediated inflammatory diseases
Rahier, Jean-Francois
Moutschen, Michel
Van Gompel, Alfons
Van Ranst, Marc
Louis, Edouard
Segaert, Siegfried
Masson, Pierre
De Keyser, Filip
RHEUMATOLOGY, 2010, 49 (10) : 1815 - 1827
[27] Chilblains in immune-mediated inflammatory diseases: a review
Dubey, Shirish
Joshi, Nilay
Stevenson, Olivia
Gordon, Caroline
Reynolds, John A.
RHEUMATOLOGY, 2022, 61 (12) : 4631 - 4642
[28] Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Romero-Bogado, Liz
Steiner, Martina
Vasallo, Israel John Thuissard
Andreu-Vazquez, Cristina
Cobo-Ibanez, Tatiana
Gomez, Alejandro Gomez
Paredes-Romero, Maria Beatriz
Esteban-Vazquez, Ana
Mendez, Laura Cebrian
De La Mano, Maria Angeles Matias
Garcia-Yubero, Cristina
Hernandez, Alicia Martinez
Ortega, Mar Esteban
Marcos, Noemi Mancenido
Pajares, Ramon
Alba, Concepcion Esteban
Santos, Raquel Guillen
Marcos, Teresa Navio
Munoz-Fernandez, Santiago
REVISTA CHILENA DE INFECTOLOGIA, 2023, 40 (06): : 618 - 625
[29] Use of TNF blockers and other targeted therapies in rare refractory immune-mediated inflammatory diseases: evidence-based or rational?
Baeten, Dominique
van Hagen, P. Martin
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2067 - 2073
[30] Anti-tumor necrosis factor-a therapies for immune-mediated and inflammatory skin diseases
Dessinioti, Clio
Stratigos, Alexander J.
Katsambas, Andreas
Antoniou, Christina
DRUG DEVELOPMENT RESEARCH, 2011, 72 (07) : 615 - 622

← 1 2 3 4 5 →